Muranski and coworkers created a transgenic mouse expressing MHC class II-restricted T cell receptor, in which CD4+ T cells recognize tyrosinase-related protein 1 (TRP-1), an antigen present both in normal melanocytes and B16 melanoma cells. The gene discussed is TYRP1; the disease is melanoma.